Liliane Chamas
Director/Miembro de la Junta en Credo Therapies Ltd. .
Perfil
Liliane Chamas is currently a Director at Amber Therapeutics Ltd.
and Credo Therapies Ltd.
She also holds the position of Principal at Oxford Science Enterprises PLC since 2019.
Ms. Chamas completed her undergraduate degree at Concordia University in 2009.
Cargos activos de Liliane Chamas
| Empresas | Cargo | Inicio |
|---|---|---|
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Inversor de Capital Privado | 01/12/2019 |
Amber Therapeutics Ltd.
 Amber Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Amber Therapeutics Ltd. is a British company that develops intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology. The company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2020 by Aidan Harold Winston Crawley. Aidan Harold Winston Crawley has been the CEO since 2020. | Director/Miembro de la Junta | 18/06/2021 |
Credo Therapies Ltd.
 Credo Therapies Ltd. Financial ConglomeratesFinance Credo Therapies Ltd. is a British dormant company that was founded in 2022. | Director/Miembro de la Junta | 05/12/2022 |
Formación de Liliane Chamas.
| Concordia University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Finance |
Amber Therapeutics Ltd.
Amber Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Amber Therapeutics Ltd. is a British company that develops intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology. The company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2020 by Aidan Harold Winston Crawley. Aidan Harold Winston Crawley has been the CEO since 2020. | Health Technology |
Credo Therapies Ltd.
Credo Therapies Ltd. Financial ConglomeratesFinance Credo Therapies Ltd. is a British dormant company that was founded in 2022. | Finance |
- Bolsa de valores
- Insiders
- Liliane Chamas
